Microfluidic platform for understanding Parkinson's disease and α-synuclein conformation

Area of Science:

• Biomedical Engineering
• Neuroscience
• Analytical Chemistry

Background:

• Parkinson's disease (PD) diagnosis is challenging, with early detection crucial for effective treatment.
• Alpha-synuclein (αSyn) protein aggregation into fibrils and toxic oligomers is a hallmark of PD pathology.
• Current diagnostic methods lack the sensitivity to detect early-stage αSyn pathology.

Purpose of the Study:

• To review the application of microfluidic systems for Parkinson's disease diagnosis.
• To explore microfluidics in single-cell analysis and αSyn protein aggregation studies.
• To discuss lab-on-a-chip technologies for detecting αSyn pathology.

Main Methods:

• Analysis of microfluidic systems utilizing microchannels (1-300 microns) for precise sample and reagent handling.
• Review of studies employing microfluidics for single-cell analysis and detection of αSyn oligomers and fibrils.
• Examination of various substrates and techniques for αSyn detection in microfluidic devices.

Main Results:

• Microfluidics enables precise control over small fluid volumes, facilitating sensitive detection of αSyn.
• Lab-on-a-chip devices show promise for analyzing αSyn aggregation at the single-cell level.
• Different substrates and detection methods are being explored for enhanced αSyn quantification.

Conclusions:

• Microfluidic systems represent a promising technological approach for the early diagnosis and monitoring of Parkinson's disease.
• The precise control and sensitivity offered by microfluidics are well-suited for studying αSyn pathology.
• Further development of microfluidic platforms can significantly improve the understanding and management of Parkinson's disease.